LI
CDNA icon

Leap Investments’s CareDx CDNA Stock Holding History

Leap Investments’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,700
Closed -$219K – 442
2019
Q3 		$219K Buy
+9,700
New +$269K 0.11% 289

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Leap Investments's CDNA Position: Q4 2019 in Review

Leap Investments sold out of CareDx (CDNA) in Q4 2019, closing a stake of 9,700 shares — an estimated $219K sold.

Leap Investments first reported a position in CDNA in Q3 2019 and held it in 1 quarter. The position peaked at $219K in Q3 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • Leap Investments reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 9,700 CareDx shares in Q4 2019, an estimated $219K.
  • Leap Investments first reported a position in CareDx in Q3 2019 and held it in 1 quarter.
  • Leap Investments's CareDx position peaked at $219K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.